to view your mail
Yahoo Finance Plus
U.S. markets close in 6 hours 20 minutes
U.S. employers added just 266,000 jobs in April
Economists were expecting 1 million.
Immunome, Inc. (IMNM)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 9:30AM EDT. Market open.
118 reactions on $IMNM conversation
Sign in to post a message.
This news is quite revealing to me. Now why would a distinguished professional leave a major firm for IMNM, unless they perceived major upside in the 120k options that is part of the pay package. Had a secure well paying job, hmmm - to me it lends much credibility to what IMNM is doing. Corleen Roche is a corporate finance and business strategist with extensive executive experience in the biopharmaceutical industry. Prior to her most recent role as the U.S. CFO for Biogen, Ms. Roche was a CFO at various biopharmaceutical companies including Sandoz, IoGenetics Inc, and Wyeth Pharmaceuticals.
Look at ODT, buy on hope is risky!!
what is the connection between $IMNM and $ENZC? Enzolytics COO Tweeted this morning and hashtagged #Immunome.
Seems like incredibly positive news to me
$IPA is way ahead of IMNM, check out the PR from last Friday. 100% clearance of covid in in vivo preclinical.
Anybody know if this offers anything better than Gritstone’s current NIAID trial for a similar thing?
I figure they have something over $50 mm million so an offering would be likely if the stock holds up but isn’t urgent.
Up trend stated. Coronavirus antibody breakthrough is crucial now.
This will fly tomorrow
Good news coming for IMNM
Bought in the 60s - it's mooning!!!
Premarket could be good clean fun tomorrow morning.
next week to 100s
I’d wait for the secondary,, they have no money and need to dilute.
Great science, great space , just need to wait for the next offer before jumping in
Soon over 60.00
Its rumored by industry sources that Immunome has drawn the interest of major investors after the recent announcement that it has isolated potent antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant in pseudo virus testing. This discovery has tripled the stock prices of Immunome and opened the doors for nearly 2M shares traded today compared to a normal trading day volume of +/- 90,000 shares. It’s a windfall for the Biotech Industry in the fight to combat the Covid-19 virus and Immunome is at the forefront.
way undervalued, I think many didn't saw the last PR, and maybe many don't know any about what's happening in EUROPE with the UK COVID-19 virus...
This could be a 500 dollar stock literally. Its the most important thing happening in the market.
Secondary coming first, then we take off!
Webull you can buy premarket 4am Monday
April jobs report: Payrolls rose by 266,000, sharply missing estimates, as unemployment rate increased to 6.1%
U.S. unemployment rises to 6.1% in April as hiring slows
Yahoo Finance Video
Recently filed taxes? A bonus stimulus check from the IRS may be on its way
Advertise with us
© 2021 Verizon Media. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research